Short Term Investments - Epizyme Inc (F:EPE) - Alpha Spread
E

Epizyme Inc
F:EPE

Watchlist Manager
Epizyme Inc
F:EPE
Watchlist
Price: 559 EUR 3.33% Market Closed
Market Cap: 92.2B EUR
Have any thoughts about
Epizyme Inc?
Write Note

Epizyme Inc
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Epizyme Inc
Short-Term Investments Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Short-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
E
Epizyme Inc
F:EPE
Short-Term Investments
$73.3m
CAGR 3-Years
-36%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Short-Term Investments
$27m
CAGR 3-Years
-21%
CAGR 5-Years
-36%
CAGR 10-Years
-31%
Gilead Sciences Inc
NASDAQ:GILD
Short-Term Investments
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Short-Term Investments
$1.2B
CAGR 3-Years
24%
CAGR 5-Years
13%
CAGR 10-Years
4%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Short-Term Investments
$7.9B
CAGR 3-Years
62%
CAGR 5-Years
37%
CAGR 10-Years
43%

See Also

What is Epizyme Inc's Short-Term Investments?
Short-Term Investments
73.3m USD

Based on the financial report for Jun 30, 2022, Epizyme Inc's Short-Term Investments amounts to 73.3m USD.

What is Epizyme Inc's Short-Term Investments growth rate?
Short-Term Investments CAGR 5Y
-7%

Over the last year, the Short-Term Investments growth was -55%. The average annual Short-Term Investments growth rates for Epizyme Inc have been -36% over the past three years , -7% over the past five years .

Back to Top